Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Agreement
Agilent Technologies, Proscia ink digital pathology distribution agreement
Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.
March 8, 2023
Exact Sciences executes private placement of convertible senior notes
Under the agreement, Exact Sciences has agreed to issue to the holder $500 million aggregate principal amount of a new series of 2% convertible senior notes due in 2030.
February 23, 2023
Quest Diagnostics, New York-Presbyterian ink laboratory services agreement
Their strategic objective is to broaden access to laboratory services for providers in New York, Connecticut, New Jersey, and beyond.
February 14, 2023
S2 Genomics, Bonsailab ink Spain, Portugal distribution agreement
S2 Genomics is partnering with Bonsailab to promote, sell, and support its Singulator 100 and 200 systems, which provide consistent isolation of single cells or nuclei from solid-tissue samples.
January 17, 2023
T2 Biosystems nabs contract extension with group purchasing organization
Products covered under the contract with Vizient, a purchasing organization for healthcare institutions, include the T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel. All detect sepsis-causing bacterial and fungal pathogens from whole blood.
December 28, 2022
Source LDPath, Ibex Medical Analytics ink agreement to deploy AI-enabled pathology platform
AI-enabled tools will be used to diagnose multiple tissue types and improve diagnostic accuracy and efficiency, Source LDPath said.
December 7, 2022
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Quest Diagnostics, Premier ink laboratory stewardship platform and services agreement
Premier members can obtain specific negotiated pricing and terms to access Quest's laboratory stewardship solution.
December 1, 2022
KSL Pulse Scientific to distribute Lucira Health COVID, flu molecular test in Canada
The test was approved by Health Canada and will be available to healthcare providers and consumers for the fall and winter COVID and flu season.
November 29, 2022
Bio-Rad Laboratories, NuProbe USA sign licensing agreement for digital PCR assays
The agreement allows NuProbe to license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays
November 8, 2022
Sense Biodetection signs distribution agreement with Biotecom for MDx platform
The agreement allows Biotecom to provide Chilean hospitals, laboratories, and clinics with the Veros molecular testing platform.
November 2, 2022
QuantuMDx inks distribution agreement with Menarini
According to the agreement, Menarini will handle the distribution and marketing of the Q-POC platform, COVID assay, and QuantuMDx’s SARS-CoV-2/Flu A/B/RSV Respiratory Panel test in the U.K. and France.
November 2, 2022
Shineco moves into point-of-care testing, inks stock purchase agreement with Chinese biotech
The stock purchase agreement is an initiative in Shineco’s strategy aimed at moving into the point-of-care testing industry.
October 25, 2022
Page 1 of 16
Next Page
